These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 35608153)

  • 1. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
    Pandey A; Achrafie L; Kodjamanova P; Tencer T; Kumar J
    Curr Med Res Opin; 2022 Sep; 38(9):1531-1541. PubMed ID: 35608153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis.
    Viscido A; Valvano M; Stefanelli G; Capannolo A; Castellini C; Onori E; Ciccone A; Vernia F; Latella G
    BMC Gastroenterol; 2022 Mar; 22(1):92. PubMed ID: 35240984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission.
    Wang H; Fewings I; Bornman L; Shadbolt B; Fadia M; Subramaniam K
    J Clin Gastroenterol; 2023 May-Jun 01; 57(5):494-500. PubMed ID: 35220375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials.
    Pai RK; D'Haens G; Kobayashi T; Sands BE; Travis S; Jairath V; De Hertogh G; Park B; McGinnis K; Redondo I; Lipitz NG; Gibble TH; Magro F
    Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):73-87. PubMed ID: 38509826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1.
    Seong G; Song JH; Kim JE; Kim TJ; Kim ER; Hong SN; Chang DK; Kim SH; Ha SY; Kim YH
    Inflamm Bowel Dis; 2023 Feb; 29(2):238-244. PubMed ID: 35396998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Yoon H; Jangi S; Dulai PS; Boland BS; Prokop LJ; Jairath V; Feagan BG; Sandborn WJ; Singh S
    Gastroenterology; 2020 Oct; 159(4):1262-1275.e7. PubMed ID: 32585306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
    Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal Healing in Ulcerative Colitis--When Zero is Better.
    Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
    J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
    Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
    J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
    Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
    World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission.
    Cushing KC; Tan W; Alpers DH; Deshpande V; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2020 Feb; 51(3):347-355. PubMed ID: 31696961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing.
    Jangi S; Yoon H; Dulai PS; Valasek M; Boland BS; Jairath V; Feagan BG; Sandborn WJ; Singh S
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1008-1016. PubMed ID: 33119168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
    Li K; Marano C; Zhang H; Yang F; Sandborn WJ; Sands BE; Feagan BG; Rubin DT; Peyrin-Biroulet L; Friedman JR; De Hertogh G
    Gastroenterology; 2020 Dec; 159(6):2052-2064. PubMed ID: 32853634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic improvement predicts endoscopic remission in patients with ulcerative colitis.
    Kim JE; Kim M; Kim MJ; Kim ER; Hong SN; Chang DK; Ha SY; Kim YH
    Sci Rep; 2024 Aug; 14(1):19926. PubMed ID: 39198522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.
    Bryant RV; Burger DC; Delo J; Walsh AJ; Thomas S; von Herbay A; Buchel OC; White L; Brain O; Keshav S; Warren BF; Travis SP
    Gut; 2016 Mar; 65(3):408-14. PubMed ID: 25986946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of fecal calprotectin levels and endoscopic scores for predicting relapse in patients with ulcerative colitis in remission.
    Ishida N; Ito T; Takahashi K; Asai Y; Miyazu T; Higuchi T; Tamura S; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Osawa S; Sugimoto K
    World J Gastroenterol; 2023 Dec; 29(47):6111-6121. PubMed ID: 38186681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis.
    Iacucci M; Smith SCL; Bazarova A; Shivaji UN; Bhandari P; Cannatelli R; Daperno M; Ferraz J; Goetz M; Gui X; Hayee B; De Hertogh G; Lazarev M; Li J; Nardone OM; Parra-Blanco A; Pastorelli L; Panaccione R; Occhipinti V; Rath T; Tontini GE; Vieth M; Villanacci V; Zardo D; Bisschops R; Kiesslich R; Ghosh S
    Gastroenterology; 2021 Apr; 160(5):1558-1569.e8. PubMed ID: 33347880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis.
    Kevans D; Kirsch R; Dargavel C; Kabakchiev B; Riddell R; Silverberg MS
    Inflamm Bowel Dis; 2020 Oct; 26(11):1722-1729. PubMed ID: 31883337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis.
    Nardone OM; Bazarova A; Bhandari P; Cannatelli R; Daperno M; Ferraz J; Goetz M; Gui X; Hayee B; De Hertogh G; Lazarev M; Li J; Parra-Blanco A; Pastorelli L; Panaccione R; Occhipinti V; Rath T; Smith SCL; Shivaji UN; Tontini GE; Vieth M; Villanacci V; Zardo D; Bisschops R; Kiesslich R; Ghosh S; Iacucci M
    United European Gastroenterol J; 2022 Mar; 10(2):147-159. PubMed ID: 35194978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.